New stomach cancer combo shows promise in early trial
NCT ID NCT00512304
First seen Apr 05, 2026 · Last updated May 21, 2026 · Updated 11 times
Summary
This study looked at whether a specific chemotherapy regimen (FOLFIRI) plus radiation is practical for stomach cancer patients. 63 people with non-spreading stomach cancer received the treatment either before or after surgery. The goal was to see if this approach is feasible and less toxic than older methods.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GASTRIC CANCER are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
University hospital
Rouen, 76031, France
Conditions
Explore the condition pages connected to this study.